Fingerprint
Dive into the research topics of 'Phase I and pharmacokinetic study of the novel redox-active agent, motexafin gadolinium, with concurrent radiation therapy in patients with locally advanced pancreatic or biliary cancers'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically